These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37092509)

  • 1. Comparison of the biological effects of gadodiamide (Omniscan) and gadoteridol (ProHance) by means of multi-organ and plasma metabolomics.
    Romano F; Di Gregorio E; Riccardi G; Furlan C; Cavallini N; Savorani F; Di Porzio A; De Tito S; Randazzo A; Gianolio E; Iaccarino N
    Analyst; 2023 May; 148(11):2415-2424. PubMed ID: 37092509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the ototoxicity of gadoteridol (ProHance) and gadodiamide (Omniscan) in mice.
    Nonoyama H; Tanigawa T; Shibata R; Tanaka H; Katahira N; Horibe Y; Takemura K; Murotani K; Ozeki N; Ueda H
    Acta Otolaryngol; 2016 Nov; 136(11):1091-1096. PubMed ID: 27315460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Speciation Analysis of Gadolinium in the Water-Insoluble Rat Brain Fraction After Administration of Gadolinium-Based Contrast Agents.
    Strzeminska I; Factor C; Robert P; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2021 Sep; 56(9):535-544. PubMed ID: 33813574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
    Frenzel T; Apte C; Jost G; Schöckel L; Lohrke J; Pietsch H
    Invest Radiol; 2017 Jul; 52(7):396-404. PubMed ID: 28125438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gd accumulation in tissues of healthy mice upon repeated administrations of Gadodiamide and Gadoteridol.
    Di Gregorio E; Iani R; Ferrauto G; Nuzzi R; Aime S; Gianolio E
    J Trace Elem Med Biol; 2018 Jul; 48():239-245. PubMed ID: 29773187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging.
    Di Gregorio E; Furlan C; Atlante S; Stefania R; Gianolio E; Aime S
    Invest Radiol; 2020 Jan; 55(1):30-37. PubMed ID: 31503081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative administrations of gadolinium-based contrast agents: risks of accumulation and toxicity of linear vs macrocyclic agents.
    Chehabeddine L; Al Saleh T; Baalbaki M; Saleh E; Khoury SJ; Hannoun S
    Crit Rev Toxicol; 2019 Mar; 49(3):262-279. PubMed ID: 30942117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium Deposition in the Brain in a Large Animal Model: Comparison of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Radbruch A; Richter H; Fingerhut S; Martin LF; Xia A; Henze N; Paulus W; Sperling M; Karst U; Jeibmann A
    Invest Radiol; 2019 Sep; 54(9):531-536. PubMed ID: 31261291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy.
    Gibby WA; Gibby KA; Gibby WA
    Invest Radiol; 2004 Mar; 39(3):138-42. PubMed ID: 15076005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Gadolinium Retention in the Healthy Rat Brain: Comparison between Gadopiclenol, Gadobutrol, and Gadodiamide.
    Funke SKI; Factor C; Rasschaert M; Lezius L; Sperling M; Karst U; Robert P
    Radiology; 2022 Oct; 305(1):179-189. PubMed ID: 35727155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion.
    Lancelot E
    Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Excretion of Gadolinium-based Contrast Agents: Linear versus Macrocyclic Agents in an Experimental Rat Model.
    Jost G; Frenzel T; Boyken J; Lohrke J; Nischwitz V; Pietsch H
    Radiology; 2019 Feb; 290(2):340-348. PubMed ID: 30422091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents.
    Strzeminska I; Factor C; Robert P; Grindel AL; Comby PO; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2020 Mar; 55(3):138-143. PubMed ID: 31917763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
    Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
    Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential toxicity evaluation and comparison within multiple mice organs after repeat injections of linear versus macrocyclic gadolinium-based contrast agents: A comprehensive and time course study.
    Kong Y; Zhang S; Wang J; Han C; Yu N; Liu Q; Wang W; Xu K
    Toxicol Lett; 2021 Oct; 350():152-161. PubMed ID: 34311048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats.
    Fretellier N; Granottier A; Rasschaert M; Grindel AL; Baudimont F; Robert P; Idée JM; Corot C
    Invest Radiol; 2019 Feb; 54(2):61-71. PubMed ID: 30394964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
    Ramalho J; Semelka RC; AlObaidy M; Ramalho M; Nunes RH; Castillo M
    Eur Radiol; 2016 Nov; 26(11):4080-4088. PubMed ID: 26911888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.